Pseudo-Richter Transformation Following BTKi Interruption in CLL: A Systematic Review of Clinical, Biological, and Pathologic Features

This publication has 16 references indexed in Scilit:

• Atypical lymphoid proliferations associated with therapeutic intervention: a report of the 2024 EA4HP/SH lymphoma workshop
  Virchows Archiv, 2025
• Richter's transformation: Transforming the clinical landscape
  Blood Reviews, 2023
• Richter Transformation of Chronic Lymphocytic Leukemia—Are We Making Progress?
  Current Hematologic Malignancy Reports, 2023
• Clinical outcome and prognostic factors of patients with Richter syndrome: real‐world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC)
  British Journal of Haematology, 2020
• Clinically indicated ibrutinib dose interruptions and reductions do not compromise long-term outcomes in CLL
  Blood, 2019
• Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice
  Leukemia & Lymphoma, 2019
• PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT)
  American Journal of Surgical Pathology, 2018
• The CARE guidelines: consensus-based clinical case report guideline development
  Journal of Clinical Epidemiology, 2014
• Diffuse large B‐cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients
  British Journal of Haematology, 2013
• Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
  New England Journal of Medicine, 2000